Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  BULGARIAN STOCK EXCHANGE  >  Sopharma Trading AD    SO5   BG1100086070

SOPHARMA TRADING AD (SO5)
Mes dernières consult.
Most popular
Report
 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials ( BGN)
Sales 2017 627 M
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 637 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0,39x
Capi. / Sales2018 0,39x
Capitalization 247 M
More Financials
Company
Sopharma Trading AD engages in the wholesale and distribution of pharmaceutical, non-drugs and medical products.It offers logistic solutions for import, storage and distribution of pharmaceutical products as well as services on the appropriate positioning of the products on the hospital and... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on SOPHARMA TRADING AD
12/01 SOPHARMA TRADING : announces closing of the acquisition of PharmaStore chain of ..
11/30 SOPHARMA TRADING : Jsc. reports 9% growth оf revenue in October, 2017
11/22 SOPHARMA TRADING : becomes the marketer for Bulgaria of the product portfolio un..
11/07 SOPHARMA TRADING : The Commission for Protection of Competition has permitted co..
10/27 SOPHARMA TRADING : Jsc. reports 9% growth for the three quarters of the year
09/29 SOPHARMA TRADING : Jsc. reports 10% revenue growth in August, 2017
07/26 SOPHARMA TRADING : Jsc. reports growth of 11% in profit before taxes and 9% in r..
07/18 SOPHARMA TRADING : The Commission for Protection of Competition in Serbia has ap..
07/14 SOPHARMA TRADING : is the leader in Pharmaceutical sector in Capital Top 100 Ran..
02/28 SOPHARMA TRADING : Jsc. reports 5% growth in revenue from sales of goods in Janu..
More news
Sector news : Generic Pharmaceuticals
03:12pDJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
11:22a Germany's Merck in fresh bid to enter U.S. MS pill market
08:48aDJTEVA PHARMACEUTICAL INDUSTRIES : Generics Giant Cuts Staff by 25% -- WSJ
07:34aDJNOVARTIS : Oncology CEO Bruno Strigini to Retire
07:25aDJALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
More sector news : Generic Pharmaceuticals
Income Statement Evolution
Managers
NameTitle
Dimitar Georgiev Dimitrov Chief Executive Officer & Independent Director
Ognian Ivanov Donev Chairman
Dimitar Bogomilov Chief Financial Officer
Denitsa Georgieva Director-Technology & Business Solutions
Alexander Kaloferov Raychev Independent Director